MRP1 has been extensively studied for its role in multidrug resistance (MDR) in cancer. The protein can pump out chemotherapeutic agents from cancer cells, thereby reducing drug accumulation and effectiveness. This makes MRP1 a critical factor in the failure of cancer treatment, particularly in malignancies such as lung cancer, breast cancer, and neuroblastoma.
